Clinical cases of statin-induced rhabdomyolysis are highly significant, as they are higher than those seen in clinical trials since clinical trials often exclude patients with predisposing risk factors, and as such do not encompass the entire patient population on statins 3 .
← all excerpts
Acute renal failure requiring renal replacement therapy secondary to rhabdomyolysis due to rosuvastatin.
1
—
—